selected publications
-
Journal Article
- Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial. Diabetes, Obesity & Metabolism. 2017
- Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin. Hypertension (Dallas, Tex.. 2016
- Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial. Diabetes care. 2016
- Alogliptin after acute coronary syndrome in patients with type 2 diabetes. New England Journal of Medicine. 2013
-
Abstract
- Hypoglycemia is associated with increased risk of cardiovascular events: results from the EXAMINE Trial [abstract 1091-P]. Diabetes. 2016
- Mortality findings from the EXAMINE Trial [abstract 1090-P]. Diabetes. 2016
- Major cardiovascular outcomes in the EXAMINE trial according to ACE inhibitor use [abstract 12-OR]. Diabetes. 2015